Endurant Capital Management LP - Q1 2023 holdings

$195 Million is the total value of Endurant Capital Management LP's 50 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 74.5% .

 Value Shares↓ Weighting
BMRN BuyBIOMARIN PHARMACEUTICAL INC$24,856,100
+184.7%
255,616
+203.0%
12.77%
+260.2%
BDX BuyBECTON DICKINSON & CO$19,023,449
+1006.5%
76,850
+1036.7%
9.77%
+1300.0%
ANTM BuyELEVANCE HEALTH INC$17,162,868
+28.3%
37,326
+43.1%
8.82%
+62.3%
SBRA BuySABRA HEALTH CARE REIT INC$13,408,115
+147.1%
1,165,923
+167.1%
6.89%
+212.6%
LH SellLABORATORY CORP AMER HLDGS$10,378,961
-51.5%
45,240
-50.2%
5.33%
-38.7%
QGEN BuyQIAGEN NV$8,216,601
+304.3%
178,894
+339.0%
4.22%
+411.6%
CI SellTHE CIGNA GROUP$7,103,478
-56.8%
27,799
-44.0%
3.65%
-45.4%
AZN SellASTRAZENECA PLCsponsored adr$6,750,608
-29.6%
97,257
-31.2%
3.47%
-10.9%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$6,746,036762,264
+100.0%
3.46%
ICLR SellICON PLC$5,730,620
-49.9%
26,830
-54.4%
2.94%
-36.6%
MRNA NewMODERNA INC$5,548,84536,130
+100.0%
2.85%
MRK SellMERCK & CO INC$5,274,071
-62.3%
49,573
-60.7%
2.71%
-52.3%
AVTR NewAVANTOR INC$4,769,501225,615
+100.0%
2.45%
BIO BuyBIO RAD LABS INCcl a$4,399,799
+168.8%
9,185
+135.9%
2.26%
+239.8%
INSM SellINSMED INC$3,921,602
-19.3%
230,006
-5.4%
2.01%
+2.1%
THC BuyTENET HEALTHCARE CORP$3,559,436
+80.3%
59,903
+48.1%
1.83%
+128.2%
SELB SellSELECTA BIOSCIENCES INC$3,011,196
-29.5%
2,166,328
-42.7%
1.55%
-10.7%
PFE NewPFIZER INC$2,989,21273,265
+100.0%
1.54%
OCUL SellOCULAR THERAPEUTIX INC$2,702,161
-9.6%
512,744
-51.8%
1.39%
+14.3%
MCK NewMCKESSON CORP$2,603,4387,312
+100.0%
1.34%
PTCT BuyPTC THERAPEUTICS INC$2,579,285
+277.8%
53,247
+197.7%
1.32%
+378.3%
DXCM NewDEXCOM INC$2,577,45322,185
+100.0%
1.32%
ARGX NewARGENX SEsponsored adr$2,286,5236,137
+100.0%
1.18%
PEAK BuyHEALTHPEAK PROPERTIES INC$2,212,049
+48.1%
100,685
+69.0%
1.14%
+87.1%
XRAY BuyDENTSPLY SIRONA INC$2,199,366
+212.7%
55,992
+153.5%
1.13%
+295.1%
TMO BuyTHERMO FISHER SCIENTIFIC INC$2,157,929
+146.6%
3,744
+135.6%
1.11%
+212.1%
CNC SellCENTENE CORP DEL$1,870,131
-86.5%
29,586
-82.4%
0.96%
-82.9%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$1,810,310
-28.5%
1,660,835
-4.2%
0.93%
-9.5%
BLUE NewBLUEBIRD BIO INC$1,669,688525,059
+100.0%
0.86%
ISEE NewIVERIC BIO INC$1,574,24864,704
+100.0%
0.81%
GRTS BuyGRITSTONE BIO INC$1,503,026
+54.0%
540,657
+91.1%
0.77%
+94.9%
ABC SellAMERISOURCEBERGEN CORP$1,465,487
-58.0%
9,153
-56.5%
0.75%
-46.8%
EHC SellENCOMPASS HEALTH CORP$1,432,081
-69.4%
26,471
-66.1%
0.74%
-61.2%
QURE NewUNIQURE NV$1,430,74671,040
+100.0%
0.74%
ZTS SellZOETIS INCcl a$1,400,426
-42.9%
8,414
-49.7%
0.72%
-27.8%
BAX BuyBAXTER INTL INC$1,399,644
+149.5%
34,508
+213.5%
0.72%
+215.4%
RMD NewRESMED INC$1,389,4926,345
+100.0%
0.71%
ZBH NewZIMMER BIOMET HOLDINGS INC$1,199,3649,283
+100.0%
0.62%
VKTX SellVIKING THERAPEUTICS INC$949,766
-76.7%
57,043
-86.8%
0.49%
-70.5%
ACRS NewACLARIS THERAPEUTICS INC$678,67883,891
+100.0%
0.35%
CTLT SellCATALENT INC$600,852
-62.1%
9,144
-74.1%
0.31%
-52.1%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$491,580
+8.9%
80,455
+13.9%
0.25%
+38.3%
CHRS NewCOHERUS BIOSCIENCES INC$444,29964,956
+100.0%
0.23%
ETNB Sell89BIO INC$298,280
-36.3%
19,585
-46.8%
0.15%
-19.5%
MRVI SellMARAVAI LIFESCIENCES HLDGS I$290,750
-5.3%
20,753
-3.3%
0.15%
+19.2%
BTAI NewBIOXCEL THERAPEUTICS INC$217,20211,640
+100.0%
0.11%
BDSX SellBIODESIX INC$210,677
-26.4%
113,267
-9.0%
0.11%
-6.9%
ADXN NewADDEX THERAPEUTICS LTDsponsored ads$114,252120,748
+100.0%
0.06%
NewATHENEX INC$56,72642,651
+100.0%
0.03%
VKTX NewVIKING THERAPEUTICS INCcall$7,359442
+100.0%
0.00%
ATNX ExitATHENEX INC$0-902,236
-100.0%
-0.05%
OYST ExitOYSTER PT PHARMA INC$0-19,927
-100.0%
-0.09%
BMEA ExitBIOMEA FUSION INC$0-33,881
-100.0%
-0.12%
INBX ExitINHIBRX INC$0-13,485
-100.0%
-0.14%
ITOS ExitITEOS THERAPEUTICS INC$0-21,041
-100.0%
-0.17%
ATNM ExitACTINIUM PHARMACEUTICALS INC$0-45,612
-100.0%
-0.20%
IGMS ExitIGM BIOSCIENCES INC$0-30,320
-100.0%
-0.21%
NTLA ExitINTELLIA THERAPEUTICS INC$0-16,401
-100.0%
-0.23%
AXSM ExitAXSOME THERAPEUTICS INC$0-11,264
-100.0%
-0.35%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-4,596
-100.0%
-0.44%
TXG Exit10X GENOMICS INC$0-30,357
-100.0%
-0.45%
BCAB ExitBIOATLA INC$0-136,382
-100.0%
-0.46%
ARWR ExitARROWHEAD PHARMACEUTICALS IN$0-28,187
-100.0%
-0.46%
CRL ExitCHARLES RIV LABS INTL INC$0-6,258
-100.0%
-0.55%
TERN ExitTERNS PHARMACEUTICALS INC$0-135,994
-100.0%
-0.56%
SILK ExitSILK RD MED INC$0-29,967
-100.0%
-0.64%
HCA ExitHCA HEALTHCARE INC$0-6,595
-100.0%
-0.64%
STRO ExitSUTRO BIOPHARMA INC$0-281,895
-100.0%
-0.92%
BNTX ExitBIONTECH SEsponsored ads$0-21,664
-100.0%
-1.32%
ALBO ExitALBIREO PHARMA INC$0-217,209
-100.0%
-1.91%
AZYO ExitAZIYO BIOLOGICS INC$0-1,259,544
-100.0%
-2.17%
ExitINVACARE CORPnote 5.000%11/1$0-10,097,000
-100.0%
-3.44%
ExitINVACARE CORPnote 5.000%11/1$0-56,727,000
-100.0%
-19.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
INVACARE HOLDINGS CorpSeptember 08, 202339,488,56984.9%
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21
SC 13G/A2023-02-14

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings